Copyright Reports & Markets. All rights reserved.

Global Drugs for Osteoarthritis Pain Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Oral
      • 1.4.3 Injection
      • 1.4.4 External
    • 1.5 Market by Application
      • 1.5.1 Global Drugs for Osteoarthritis Pain Market Share by Application (2014-2025)
      • 1.5.2 Medical Care
      • 1.5.3 Personal Care
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Drugs for Osteoarthritis Pain Market Size
    • 2.2 Drugs for Osteoarthritis Pain Growth Trends by Regions
      • 2.2.1 Drugs for Osteoarthritis Pain Market Size by Regions (2014-2025)
      • 2.2.2 Drugs for Osteoarthritis Pain Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Drugs for Osteoarthritis Pain Market Size by Manufacturers
      • 3.1.1 Global Drugs for Osteoarthritis Pain Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Drugs for Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI)
    • 3.2 Drugs for Osteoarthritis Pain Key Players Head office and Area Served
    • 3.3 Key Players Drugs for Osteoarthritis Pain Product/Solution/Service
    • 3.4 Date of Enter into Drugs for Osteoarthritis Pain Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Drugs for Osteoarthritis Pain Market Size by Type (2014-2019)
    • 4.2 Global Drugs for Osteoarthritis Pain Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Drugs for Osteoarthritis Pain Market Size (2014-2019)
    • 5.2 Drugs for Osteoarthritis Pain Key Players in United States
    • 5.3 United States Drugs for Osteoarthritis Pain Market Size by Type
    • 5.4 United States Drugs for Osteoarthritis Pain Market Size by Application

    6 Europe

    • 6.1 Europe Drugs for Osteoarthritis Pain Market Size (2014-2019)
    • 6.2 Drugs for Osteoarthritis Pain Key Players in Europe
    • 6.3 Europe Drugs for Osteoarthritis Pain Market Size by Type
    • 6.4 Europe Drugs for Osteoarthritis Pain Market Size by Application

    7 China

    • 7.1 China Drugs for Osteoarthritis Pain Market Size (2014-2019)
    • 7.2 Drugs for Osteoarthritis Pain Key Players in China
    • 7.3 China Drugs for Osteoarthritis Pain Market Size by Type
    • 7.4 China Drugs for Osteoarthritis Pain Market Size by Application

    8 Japan

    • 8.1 Japan Drugs for Osteoarthritis Pain Market Size (2014-2019)
    • 8.2 Drugs for Osteoarthritis Pain Key Players in Japan
    • 8.3 Japan Drugs for Osteoarthritis Pain Market Size by Type
    • 8.4 Japan Drugs for Osteoarthritis Pain Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Drugs for Osteoarthritis Pain Market Size (2014-2019)
    • 9.2 Drugs for Osteoarthritis Pain Key Players in Southeast Asia
    • 9.3 Southeast Asia Drugs for Osteoarthritis Pain Market Size by Type
    • 9.4 Southeast Asia Drugs for Osteoarthritis Pain Market Size by Application

    10 India

    • 10.1 India Drugs for Osteoarthritis Pain Market Size (2014-2019)
    • 10.2 Drugs for Osteoarthritis Pain Key Players in India
    • 10.3 India Drugs for Osteoarthritis Pain Market Size by Type
    • 10.4 India Drugs for Osteoarthritis Pain Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Drugs for Osteoarthritis Pain Market Size (2014-2019)
    • 11.2 Drugs for Osteoarthritis Pain Key Players in Central & South America
    • 11.3 Central & South America Drugs for Osteoarthritis Pain Market Size by Type
    • 11.4 Central & South America Drugs for Osteoarthritis Pain Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Drugs for Osteoarthritis Pain Introduction
      • 12.1.4 Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 Johnson & Johnson
      • 12.2.1 Johnson & Johnson Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Drugs for Osteoarthritis Pain Introduction
      • 12.2.4 Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2014-2019)
      • 12.2.5 Johnson & Johnson Recent Development
    • 12.3 GlaxoSmithKline
      • 12.3.1 GlaxoSmithKline Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Drugs for Osteoarthritis Pain Introduction
      • 12.3.4 GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2014-2019)
      • 12.3.5 GlaxoSmithKline Recent Development
    • 12.4 Bayer
      • 12.4.1 Bayer Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Drugs for Osteoarthritis Pain Introduction
      • 12.4.4 Bayer Revenue in Drugs for Osteoarthritis Pain Business (2014-2019)
      • 12.4.5 Bayer Recent Development
    • 12.5 Eli Lilly
      • 12.5.1 Eli Lilly Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Drugs for Osteoarthritis Pain Introduction
      • 12.5.4 Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2014-2019)
      • 12.5.5 Eli Lilly Recent Development
    • 12.6 Novartis
      • 12.6.1 Novartis Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Drugs for Osteoarthritis Pain Introduction
      • 12.6.4 Novartis Revenue in Drugs for Osteoarthritis Pain Business (2014-2019)
      • 12.6.5 Novartis Recent Development
    • 12.7 Sanofi
      • 12.7.1 Sanofi Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Drugs for Osteoarthritis Pain Introduction
      • 12.7.4 Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2014-2019)
      • 12.7.5 Sanofi Recent Development
    • 12.8 Horizon Pharma
      • 12.8.1 Horizon Pharma Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Drugs for Osteoarthritis Pain Introduction
      • 12.8.4 Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2014-2019)
      • 12.8.5 Horizon Pharma Recent Development
    • 12.9 Abbott
      • 12.9.1 Abbott Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Drugs for Osteoarthritis Pain Introduction
      • 12.9.4 Abbott Revenue in Drugs for Osteoarthritis Pain Business (2014-2019)
      • 12.9.5 Abbott Recent Development
    • 12.10 Mylan
      • 12.10.1 Mylan Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Drugs for Osteoarthritis Pain Introduction
      • 12.10.4 Mylan Revenue in Drugs for Osteoarthritis Pain Business (2014-2019)
      • 12.10.5 Mylan Recent Development
    • 12.11 Daiichi Sankyo
    • 12.12 TEVA
    • 12.13 Almatica Pharma
    • 12.14 Astellas Pharma
    • 12.15 Tide Pharmaceutical
    • 12.16 Iroko Pharmaceuticals
    • 12.17 Hengrui Pharmaceutical
    • 12.18 Abiogen Pharma

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
      Geographically, the global Drugs for Osteoarthritis Pain market has been segmented into North America, Europe, China, Japan, Rest of Asia (RoA), and Rest of World (RoW). The North America held the largest share in the global market, its revenue of global market exceeds 38% in 2017. The next is Europe.
      In 2018, the global Drugs for Osteoarthritis Pain market size was 7440 million US$ and it is expected to reach 11600 million US$ by the end of 2025, with a CAGR of 5.7% during 2019-2025.

      This report focuses on the global Drugs for Osteoarthritis Pain status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drugs for Osteoarthritis Pain development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      Johnson & Johnson
      GlaxoSmithKline
      Bayer
      Eli Lilly
      Novartis
      Sanofi
      Horizon Pharma
      Abbott
      Mylan
      Daiichi Sankyo
      TEVA
      Almatica Pharma
      Astellas Pharma
      Tide Pharmaceutical
      Iroko Pharmaceuticals
      Hengrui Pharmaceutical
      Abiogen Pharma

      Market segment by Type, the product can be split into
      Oral
      Injection
      External

      Market segment by Application, split into
      Medical Care
      Personal Care

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Drugs for Osteoarthritis Pain status, future forecast, growth opportunity, key market and key players.
      To present the Drugs for Osteoarthritis Pain development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Drugs for Osteoarthritis Pain are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now